[2-C-14] 5-FLUOROURACIL METABOLISM TO [(CO2)-C-14]

被引:0
作者
RABINOWITZ, JL
机构
[1] Radioisotope research, Veterans Affairs Medical Center, University of Pennsylvania, Philadelphia, Pennsylvania
关键词
FLUOROURACIL; NOVIKOFF ASCITES; TUMOR TREATMENT; FIBROSARCOMA;
D O I
10.1002/jlcr.2580291203
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The rate of (CO2)-C-14 production from 2-C-14-5-FU was measured in rats bearing the Novikoff ascites hepatoma. Tracer amounts were injected and (CO2)-C-14 collected over a 6-hour period. As the tumor cells proliferated the rate of 2-C-14-5-FU oxidation decreased markedly over the approximately 12 +/- 2 days between implantation of tumor cells and death. On the day of innoculation of tumor cells, oxidation proceeded nearly linearly until almost 50% of the injected 2-C-14-5-FU was converted to (CO2)-C-14 in about 4 hours. With time after tumor innoculation, the rate of (CO2)-C-14 collection declined; ten days after innoculation only about 27% was oxidized by 4 hours, and at the terminal stage it declined to about 18% over 4 hours. Calculated from the time curves, the time oxidation of 25% of the injected trace dose increased from 88 +/- 27 min to 195 +/- 42 min after ten days, to 300 +/- 59 min at the moribund state after 12 +/- 2 days. Similar decreases in oxidation rate of 5-FU were observed during growth of a solid implanted mammary carcinoma and for two other 2-C-14-labelled pyrimidines, uracil and thymine injected in trace quantities. By comparing cancer subjects with themselves at different time-intervals from the onset of the disease and treatment, it might be possible to guage treatment dosages in the progress of the disease.
引用
收藏
页码:1277 / 1282
页数:6
相关论文
共 14 条
[1]  
CHASE G, 1990, RADIOISOTOPE METHODO, P471
[2]  
CHAUDHURI NK, 1958, BIOCHEM PHARMACOL, V1, P328
[4]  
FRAILE RJ, 1980, CANCER RES, V40, P2223
[5]  
Gustavsson B, 1981, Acta Chir Scand Suppl, V504, P1
[6]  
HEGGIE GD, 1987, CANCER RES, V47, P2203
[7]   CHEMICAL CONSEQUENCES OF INCORPORATION OF 5-FLUOROURACIL INTO DNA AS STUDIED BY NMR [J].
KREMER, AB ;
MIKITA, T ;
BEARDSLEY, GP .
BIOCHEMISTRY, 1987, 26 (02) :391-397
[8]   A CONVENIENT SYNTHESIS OF URACIL 2-C-14 FROM UREA [J].
MANDEL, HG ;
BROWN, CL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1952, 74 (09) :2439-2440
[9]  
MUKHERJEE KL, 1963, CANCER RES, V23, P49
[10]   FLUOROURACIL - BIOCHEMISTRY AND PHARMACOLOGY [J].
PINEDO, HM ;
PETERS, GFJ .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (10) :1653-1664